Neurocenter Finland Annual Event brings together various actors involved in neurosciences: researchers, clinicians, companies from start-ups and health tech to pharma, investors, patient organisations and stakeholders at large.

Plenty of time has been reserved for networking and partnering up!

As a part of the Annual Event we are happy to organize networking evening in King’s Crown with participatory pitching training given by an excellent expert, Elsa Ervasti. Snacks and drinks will also be served. Please, note that the networking event capacity is limited to 65 first registered.

You are welcome to join either the networking evening, main scientific event or both!

Please follow the event website and social media @NeurocenterFI and LinkedIn to stay informed of current updates. We will send you necessary information for your participation by e-mail closer to the time.

Participation: For free! Sign up before November 23rd 2023! 


For more information:
Pirkko Kurvinen, Coordinator

Wednesday 29.11.2023

Networking Event

Place: King’s Crown, Kuninkaankatu 22, Kuopio

18:00  Welcome
18:15   Food and drinks available
18:45  About the importance of networking
19:00  Participatory pitching training, Elsa Ervasti, Speakersforum
Elsa will talk about how to build a great pitch and how to pitch for funding, co-operation and new business.
20:15   Free networking
21:00  The event ends

Thursday 30.11.2023

Main Scientific Event

Place:  University of Eastern Finland, Medistudia MS300, Yliopistonrinne 3, Kuopio

Thursday 30.11.2023

08:30Registration and Morning coffee in Medistudia’s lobby
09:00Eero Rissanen and Hasse Karlsson, Neurocenter Finland
09:15Translational research in neuroscience today
09:20Johanna Mäkelä, FINBB
Fingenious – the Gateway to Finnish Biobanks and Biomedical Research
09:35Annakaisa Haapasalo, Kuopio Brain&Mind
Patient-derived models as platforms for discovering molecular disease mechanisms and research-based biomarker and therapeutic targets
09:50Elmo Pulli, Turku Brain&Mind Center
MRI-sequences optimization and reproducibility
10:05Vania Neves, Peprotech Thermo Fisher Scientific
PeproTech Recombinant Proteins
10:20Harri Piitulainen, Jyväskylä Brain&Mind
Role of proprioception in movement disorders
10:35Break & networking. Partners' stands
10:55Methods and biomarkers; "From bench to bedside and from bedside to bench"
11:00Heikki Tanila, Kuopio Brain & Mind
Why to study Alzheimer neuropathology in a mouse model
11:15Olga Surova, Somalogic
Advancing Translational Biomarker Research with SomaScan assay
11:30Susanne Fabre, BioArctic
The role of translational biomarkers in drug discovery
11:45Elina Jokinen, Novartis
Neurofilament as a biomarker in MS - are we ready to move from bench to bedside?
12:00Jaakko Puttonen, Teva
Migraine - New opportunities for preventive treatments
12:15Lunch in Medistudia's lobby
13:15From innovation to Business
13:20Saara Rissanen, Adamant Health
From innovation to business
13:35Markus Aittokallio, Stellar Q
The Future of Disease Monitoring
13:50Juho Seppänen (Uef), Kaj Koivunen (JyU), Artturi Suominen (UEF), Valtteri Roinila (UEF)
Olvi Foundation Neurochallenge winner 2023 Team Avanto - Discovering programmatic solutions for neurodegenerative diseases
14:05Discussion and QA
14:20Afternoon coffee & networking. Partners' stands
14:50How to build multi-organization cross-boundary partnerships? Views from academics, clinics and companies. How could we together enhance the success of the future treatments and speed up their development? Mikael von und zu Fraunberg as a moderator
14:55Introduction from academics and clinics : Early Alzheimer's disease pathology in living human cortex samples: the potential for diagnostics and precision treatments​
Mikko Hiltunen, Tarja Malm and Ville Leinonen, Kuopio Brain & Mind​ ​
15:25How to build multi-organization cross-boundary partnerships?​
Companies' perspectives: Anssi Linnankivi/Roche and Merja Jaronen/Merck​
15:40Discussion between the different parties +audience
Mikko Hiltunen, Tarja Malm, Ville Leinonen/Kuopio Brain&Mind, Merja Jaronen/Merck, Anssi Linnankivi/Roche and Saara Rissanen/Adamant Health
16:00The program ends